KEVIN MACKENZIE to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications KEVIN MACKENZIE has written about Cytochrome P-450 CYP3A Inhibitors.
Connection Strength
0.056
-
Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC-MS-Based Metabolomic Approaches. Chem Res Toxicol. 2023 08 21; 36(8):1427-1438.
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.